오수유 물 추출물의 선천 면역 활성과 염증 억제 효과
Innate Immunity Activation and Anti-Inflammation Effects of Evodia Rutaecarpine Water Extract
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study was designed to examine immuno-modulatory effects of Evodia Rutaecarpine by activating innate immune system and inhibiting inflammation. Methods: First, Cell cytotoxicity was examined with 4T1 breast carcinoma and TG-induced macrophage. To investigate activating innate immune system of Evodiamine Rutacarpine Extract (ERE) on macrophage, we tested tumor necrosis factor-alpha (TNF-α), interleukin-12 (IL-12), and interleukin-6 (IL-6). In addition, TNF-α and nitric oxide (NO) induced by lipopolysaccharide (LPS) were measured after treating with ERE to observe innate immune modulating effect of ERE on RAW 264.7 cell. Also, mitogen-activated protein kinase (MAPK) and nuclear factor κB (NF-κB) were examined by western blot analysis. Results: In cytotoxicity analysis, ERE significantly affected tumor cell growth above specific concentration. Also, ERE significantly affected macrophage growth above specific concetration. As compared with the control group, the production of TNF-α, IL-12 and IL-6 were increased in TG-induced macrophage. As compared with the control group, TNF-α and IL-6 were significantly up-regulated in RAW 264.7 cell. The expression of TNF-α and NO induced by LPS after treating ERE was significantly decreased compared with control group. In addition, We observed ERE inhibited the phosphorylation levels of p-extracellular signal-regulated kinase (p-ERK), p-Jun N-terminal kinase (p-JNK), and p-p38 in western blotting by treating ERE on RAW 264.7 cell. Conclusions: ERE seems to have considerable impact on the anti-cancer effect by activation of innate immune system and inflammation control.
Abstract
Objectives: This study was designed to examine immuno-modulatory effects of Evodia Rutaecarpine by activating innate immune system and inhibiting inflammation. Methods: First, Cell cytotoxicity was examined with 4T1 breast carcinoma and TG-induced macrophage. To investigate activating innate immune system of Evodiamine Rutacarpine Extract (ERE) on macrophage, we tested tumor necrosis factor-alpha (TNF-α), interleukin-12 (IL-12), and interleukin-6 (IL-6). In addition, TNF-α and nitric oxide (NO) induced by lipopolysaccharide (LPS) were measured after treating with ERE to observe innate immune modulating effect of ERE on RAW 264.7 cell. Also, mitogen-activated protein kinase (MAPK) and nuclear factor κB (NF-κB) were examined by western blot analysis. Results: In cytotoxicity analysis, ERE significantly affected tumor cell growth above specific concentration. Also, ERE significantly affected macrophage growth above specific concetration. As compared with the control group, the production of TNF-α, IL-12 and IL-6 were increased in TG-induced macrophage. As compared with the control group, TNF-α and IL-6 were significantly up-regulated in RAW 264.7 cell. The expression of TNF-α and NO induced by LPS after treating ERE was significantly decreased compared with control group. In addition, We observed ERE inhibited the phosphorylation levels of p-extracellular signal-regulated kinase (p-ERK), p-Jun N-terminal kinase (p-JNK), and p-p38 in western blotting by treating ERE on RAW 264.7 cell. Conclusions: ERE seems to have considerable impact on the anti-cancer effect by activation of innate immune system and inflammation control.
참고문헌 (43)
- Bradley F, "The vaginal microbiome amplifies sex hormone associated cyclic changes in cervicovaginal inflammation and epithelial barrier disruption", Am J Reprod Immunol, 80(1), pp.1~13 (2018)[DOI]
- de Ziegler D, "Inflammation and uterine fibrosis : the possible role of chronic endometritis", Fertil Steril, 111(5), pp.890~891 (2019)
- Romero R, "Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes", Am J Reprod Immunol, 72(5), pp.458~474 (2014)
- Macciò A, "Inflammation and Ovarian cancer", Cytokine, 58(2), pp.133~147 (2012)
- Modugno F, "Inflammation and endometrial cancer : a hypothesis", Cancer Epidomol Biomarkers Prev, 14(12), pp.2840~2847 (2005)
- Zhong Z, "Autophagy, Inflammation, and Immunity : A Troika Governing Cancer and Its Treatment", Cell, 166(2), pp.288~298 (2016)
- Frankel T, "The Role of Tumor Micro environment in Cancer Immunotherapy", Adv Exp Med Biol, 1036, pp.51~64 (2017)
- Vinay DS, "Immune evasion in cancer: Mechanistic basis and therapeutic strategies", Semin Cancer Biol., 35(Suppl), pp.S185~S198 (2015)
- Dae-Young Lee, "Anti-Cancer Effects of Panax Ginseng Berry Polysaccharides via Activation of Immune-Related Cells", Frontiers in Pharmacology, 10, pp.1411~ (2019), Frontiers Media SA[DOI]
- Lee KW, "Rhus Verniciflua Stokes extract induces inhibition of cell growth and apoptosis in human chronic myelogenous leukemia K562 cells", Oncol Rep, 39(3), pp.1141~1147 (2018)
- Basnet P, "Curcumin : an anti-inflammatory molecule from a curry spice on the path to cancer treatment", Molecules, 16(6), pp.4567~4598 (2011)
- 황혜진, "유근피 추출물이 대식세포 면역조절에 미치는 영향", 생명과학회지, 26(1), pp.50~58 (2016), 한국생명과학회
- National College of Korean Medicine Textbook Compilation Committee, "Herbology", pp.379~380 (2011), Younglimsa
- Liao JF, "Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components", Chin Med, 6, pp.1~8 (2011)[DOI]
- Yoon JY, "Methanol extract of Evodia Lepta displays Syk", Src targeted anti-inflammatory activity, 2013, pp.148(3), 999~1007
- Tian KM, "Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia Rutaecarpa", Pharmacol Res, 141, pp.541~550 (2019)
- Li X, "Evodiamine and rutaecarpine from Tetradium Ruticarpum in the treatment of liver diseases", Phytomedicine, 68, pp.153180~ (2020)[DOI]
- Bak EJ, "Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes", Int J Obes(Lond), 34(2), pp.250~260 (2010)
- Kobayashi Y, "The nociceptive and anti-nociceptive effects of evodiamine from fruits of Evodia Rutaecarpa in mice", Planta Med, 69(5), pp.425~428 (2003)
- Wang QS, "Protective effects of alginate-chitosan microspheres loaded with alkaloids from Coptis Chinensis Franch. and Evodia Rutaecarpa (Juss.)Benth. (Zuojin Pill) against ethanolinduced acute gastric mucosal injury in rats", Drug Des Devel Ther, 9, pp.6151~6165 (2015)
- Elinav E, "Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms", Nat Rev Cancer, 13, pp.759~771 (2013)
- Chen S, "Mechanisms regulating PD-L1 expression on tumor and immune cells", J Immunother Cancer, 7(1), pp.305~ (2019)[DOI]
- Vinay DS, "Immune evasion in cancer: Mechanistic basis and therapeutic strategies", Semin Cancer Biol, 35(Suppl), pp.S185~S198 (2015)
- Pauken KE, "Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities", Trends Immunol, 40(6), pp.511~523 (2019)
- Abdel-Wahab N, "Adverse Events in Cancer Immunotherapy", Adv Exp Med Biol, 995, pp.155~174 (2017)
- Lee SJ, "Bonchogangmok", pp.542~544 (2018), Munsacheol Publishing Co
- Heo J, "Dongeuibogam", pp.1152~ (2004), Dongeuibogam Publishing Co
- Chiou WF, "Evodia rutaecarpa protects against circulation failure and organ dysfunction in endotoxaemic rats through modulating nitric oxide release", J Pharm Pharmacol, 54(10), pp.1399~1405 (2002)
- Du J, "Evodiamine induces apoptosis and inhibits metastasis in MDA-MB-231 human breast cancer cells in vitro and in vivo", Oncol Rep, 30(2), pp.685~694 (2013)
- Wang KL, "Anti-Proliferative Effects of Evodiamine on Human Breast Cancer Cells", PLoS One, 8(6), pp.e67297~ (2013)
- Chen TC, "Evodiamine from Evodia Rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells", Phytomedicine, 23(1), pp.68~78 (2016)
- Fang C, "Evodiamine induces G2", M arrest and apoptosis via mithochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells, 2014, pp.9(12), e115204~
- Chien CC, "Activation of JNK contributes to evodiamine-induced apoptosis and G2", M arrest in human colorectal carcinoma cells: a structureactivity study of evodiamine, 2014, pp.9(6), e99729~
- Yue G, "Synergistic anticancer effects of polyphyllin I and evodiamine on freshly removed human gastric tumors", PLoS One, 8(6), pp.e65164~ (2013)
- Sachita K, "vitro assessment of the anticancer potential of evodiamine in human oral cancer cell lines", Phytother Res, 29(8), pp.1145~1151 (2015)
- Yang J, "Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof1 in hepatocellular carcinoma cells", Cancer Lett, 328(2), pp.243~251 (2013)
- Kan SF, "Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3", J Cell Biochem, 101(1), pp.44~56 (2007)
- Wang C, "Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K", Akt, NF-kB signaling pathways and augmented by ubiquitin-proteasome inhibition, pp.Toxicol in Vitro, 2010[DOI]
- Gajewski TF, "Innate and adaptive immune cells in the tumor microenvironment", Nat Immunol, 14(10), pp.1014~1022 (2013)
- Diakos CI, "Cancer-related inflammation and treatment effectiveness", Lancet Oncol, 15(11), pp.e493~e503 (2014)
- Chen DS, "Oncology meets immunology: the cancer-immunity cycle", Immunity, 39(1), pp.1~10 (2013)
- Chen LQ, "Nitric oxide production inhibition and mechanism of phenanthrene analogs in lipopolysaccharide-stimulated RAW264.7 macrophages", Bioorg Med Chem Lett, 26(10), pp.2521~2525 (2016)
- Takada Y, "Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NFkappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion", J Biol Chem, 280(7), pp.17203~17212 (2005)